140 related articles for article (PubMed ID: 37784000)
1. The Clinical Impact of Change in the C-Reactive Protein/Albumin Ratio in Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T; Maezawa Y; Hashimoto I; Hara K; Komori K; Otani K; Kazama K; Sawazaki S; Numata M; Kawahara S; Cho H; Morita J; Segami K; Tanabe M; Yukawa N; Saito A; Rino Y; Ogata T; Oshima T
J Gastrointest Cancer; 2024 Mar; 55(1):383-390. PubMed ID: 37784000
[TBL] [Abstract][Full Text] [Related]
2. The Clinical Impact of Change in the Neutrophil to Lymphocyte Ratio During the Perioperative Period in Gastric Cancer Patients Who Receive Curative Gastrectomy.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kazama K; Numata M; Otani K; Sawazaki S; Cho H; Morita J; Kawahara S; Tanabe M; Yukawa N; Saito A; Ogata T; Rino Y; Oshima T
J Gastrointest Cancer; 2024 Mar; 55(1):402-409. PubMed ID: 37889434
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and clinicopathological significance of C-reactive protein/albumin ratio (CAR) in patients with gastric cancer: A meta-analysis.
Yu J; Liu H; Zeng X; Zhao Y; Jiang D; Lu H; Qian J
PLoS One; 2021; 16(4):e0250295. PubMed ID: 33901218
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Plasma Fibrinogen and Serum Albumin Score Is an Independent Prognostic Factor for Resectable Stage II-III Gastric Cancer.
Wu M; Pan Y; Jia Z; Wang Y; Yang N; Mu J; Zhou T; Guo Y; Jiang J; Cao X
Dis Markers; 2019; 2019():9060845. PubMed ID: 31781312
[TBL] [Abstract][Full Text] [Related]
5. The Clinical Influence of the C-Reactive Protein-to-Albumin Ratio in Patients Who Received Curative Treatment for Gastric Cancer.
Aoyama T; Nakazono M; Segami K; Nagasawa S; Kano K; Yamada T; Maezawa Y; Hara K; Hashimoto I; Suematsu H; Watanabe H; Takahashi K; Numata M; Tamagawa H; Yukawa N; Rino Y; Ogata T; Oshima T
In Vivo; 2021; 35(6):3475-3482. PubMed ID: 34697184
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Impact of the Prognostic Immune and Nutritional Index in Gastric Cancer Patients Who Received Curative Treatment.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Tamagawa A; Cho H; Morita J; Tanabe M; Numata M; Kawahara S; Oshima T; Saito A; Yukawa N
Anticancer Res; 2024 May; 44(5):2231-2238. PubMed ID: 38677750
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin and Neutrophil-Lymphocyte Ratio in Gastric Cancer Patients.
Saito H; Kono Y; Murakami Y; Shishido Y; Kuroda H; Matsunaga T; Fukumoto Y; Osaki T; Ashida K; Fujiwara Y
World J Surg; 2018 Jun; 42(6):1819-1825. PubMed ID: 29270656
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.
Toyokawa T; Muguruma K; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Yashiro M; Ohira M
BMC Cancer; 2020 Jun; 20(1):517. PubMed ID: 32493247
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of the C-Reactive Protein/Albumin Ratio and Systemic Immune-Inflammation Index for Patients With Colorectal Liver Metastasis Undergoing Curative Resection.
Deng Y; Zhao Y; Qin J; Huang X; Wu R; Zhou C; Pan Z
Pathol Oncol Res; 2021; 27():633480. PubMed ID: 34257601
[No Abstract] [Full Text] [Related]
10. Preoperative C-reactive protein-to-albumin ratio and clinical outcomes after resection of colorectal liver metastases.
Sakamoto Y; Mima K; Imai K; Miyamoto Y; Tokunaga R; Akiyama T; Daitoku N; Hiyoshi Y; Iwatsuki M; Nagai Y; Baba Y; Iwagami S; Yamashita YI; Yoshida N; Baba H
Surg Oncol; 2020 Dec; 35():243-248. PubMed ID: 32932221
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the preoperative C-reactive protein-to-albumin ratio in patients with colorectal cancer.
Tamagawa H; Aoyama T; Numata M; Maezawa Y; Kazama K; Astumi Y; Hara K; Kano K; Yukawa N; Saeki H; Godai T; Oshima T; Goda M; Rino Y; Masuda M
J Cancer Res Ther; 2021; 17(4):1075-1080. PubMed ID: 34528567
[TBL] [Abstract][Full Text] [Related]
12. Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection.
Kuroda D; Sawayama H; Kurashige J; Iwatsuki M; Eto T; Tokunaga R; Kitano Y; Yamamura K; Ouchi M; Nakamura K; Baba Y; Sakamoto Y; Yamashita Y; Yoshida N; Chikamoto A; Baba H
Gastric Cancer; 2018 Mar; 21(2):204-212. PubMed ID: 28656485
[TBL] [Abstract][Full Text] [Related]
13. Complete blood count-based inflammatory score (CBCS) is a novel prognostic marker for gastric cancer patients after curative resection.
Lin JX; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Li P
BMC Cancer; 2020 Jan; 20(1):11. PubMed ID: 31906893
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.
Jiang Y; Gu H; Zheng X; Pan B; Liu P; Zheng M
Pathol Oncol Res; 2021; 27():1609946. PubMed ID: 34992504
[No Abstract] [Full Text] [Related]
15. Postoperative C-reactive protein/albumin ratio as a novel predictor for short-term complications following gastrectomy of gastric cancer.
Sun F; Ge X; Liu Z; Du S; Ai S; Guan W
World J Surg Oncol; 2017 Oct; 15(1):191. PubMed ID: 29065877
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer.
Kudou K; Saeki H; Nakashima Y; Kamori T; Kawazoe T; Haruta Y; Fujimoto Y; Matsuoka H; Sasaki S; Jogo T; Hirose K; Hu Q; Tsuda Y; Kimura K; Ando K; Oki E; Ikeda T; Maehara Y
J Gastroenterol Hepatol; 2019 Feb; 34(2):355-363. PubMed ID: 30119141
[TBL] [Abstract][Full Text] [Related]
18. The C-reactive protein to albumin ratio is an excellent prognostic predictor for gallbladder cancer.
Bao Y; Yang J; Duan Y; Chen Y; Chen W; Sun D
Biosci Trends; 2021 Jan; 14(6):428-435. PubMed ID: 33239498
[TBL] [Abstract][Full Text] [Related]
19. Impact of skeletal muscle mass in patients with unresectable gastric cancer who received palliative first-line chemotherapy based on 5-fluorouracil.
Matsunaga T; Saito H; Miyauchi W; Shishido Y; Miyatani K; Morimoto M; Murakami Y; Hanaki T; Kihara K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Fujiwara Y
BMC Cancer; 2021 Nov; 21(1):1219. PubMed ID: 34774016
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of preoperative C-reactive protein to albumin ratio in patients with thymic epithelial tumors: a retrospective study.
Huang YY; Liu X; Liang SH; Hu Y; Ma GW
BMC Cancer; 2022 Nov; 22(1):1183. PubMed ID: 36397047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
